Oncology Pipeline Insight Report, 2024: Emerging Therapies, Key Products, Leading Companies, Unmet Needs And More

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Oncology - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets's offering.

The report outlays comprehensive insights of present clinical development scenario and growth prospects across the Oncology market. A detailed picture of the Oncology pipeline landscape is provided, which includes the disease overview and Oncology treatment guidelines.

The assessment part of the report embraces in-depth Oncology commercial assessment and clinical assessment of the Oncology pipeline products from the pre-clinical developmental phase to the marketed phase.

In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Oncology collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
The report provides insights into:

• All of the companies that are developing therapies for the treatment of Oncology with aggregate therapies developed by each company for the same.
• Different therapeutic candidates segmented into early-stage, mid-stage and late stage of development for the Oncology treatment.
• Oncology key players involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of Oncology market.

Key Questions Answered

• What are the current options for Oncology treatment?
• How many companies are developing therapies for the treatment of Oncology?
• What are the principal therapies developed by these companies in the industry?
• How many therapies are developed by each company for the treatment of Oncology?
• How many Oncology emerging therapies are in early-stage, mid-stage, and late stage of development for the treatment of Oncology?
• Out of total pipeline products, how many therapies are given as a monotherapy and in combination with other therapies?
• What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and major licensing activities that will impact Oncology market?
• Which are the dormant and discontinued products and the reasons for the same?
• What is the unmet need for current therapies for the treatment of Oncology?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing Oncology therapies?
• What are the clinical studies going on for Oncology and their status?
• What are the results of the clinical studies and their safety and efficacy?
• What are the key designations that have been granted for the emerging therapies for Oncology?
• How many patents are granted and pending for the emerging therapies for the treatment of Oncology?

Key Topics Covered

1. Report Introduction
2. Oncology
3. Oncology Current Treatment Patterns
4. Oncology - Analytical Perspective
5. Therapeutic Assessment
6. Oncology Late Stage Products (Phase-III)
7. Oncology Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Oncology Discontinued Products
13. Oncology Product Profiles
14. Oncology Key Companies
15. Oncology Key Products
16. Dormant and Discontinued Products
17. Oncology Unmet Needs
18. Oncology Future Perspectives
19. Oncology Analyst Review
20. Appendix
21. Report Methodology
For more information about this drug pipelines report visit

About ResearchAndMarkets
ResearchAndMarkets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN31052024004107003653ID1108280531